A Case Report of NMDAR Encephalopathy
Completed
- Conditions
- Anti-NMDA Receptor EncephalitisMature TeratomaParaneoplastic Syndromes
- Registration Number
- NCT06915103
- Lead Sponsor
- Mayo Clinic
- Brief Summary
This case illustrates the clinical, radiologic, and histopathologic features of Anti-NMDAR encephalitis and underscores the importance of MRI in detecting ovarian teratomas when pelvic ultrasound is inconclusive.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 1
Inclusion Criteria
- Suspected Anti-NMDA Encephalitis
Exclusion Criteria
- Inability to consent
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Anti-NMDA Encephalitis 1 week Diagnosis of Anti-NMDA Encephalitis based on pelvic MRI
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
NMDA receptor autoantibody pathogenesis mechanisms and therapeutic targets in encephalitis
Comparative effectiveness of MRI versus pelvic ultrasound for ovarian teratoma detection in paraneoplastic syndromes
Biomarkers for NMDAR encephalitis patient stratification and response prediction in paraneoplastic syndromes
Adverse event management strategies in NMDAR encephalitis with teratoma-associated paraneoplastic syndromes
NCT06915103 MRI detection of ovarian teratomas in NMDAR encephalitis case report insights
Trial Locations
- Locations (1)
Mayo Clinic in Florida
🇺🇸Jacksonville, Florida, United States
Mayo Clinic in Florida🇺🇸Jacksonville, Florida, United States